Literature DB >> 26494293

Prostatic Urethral Lift Vs Prostate Arterial Embolization: Novel Nonablative Strategies in the Management of Lower Urinary Tract Symptoms Secondary to Benign Prostate Hyperplasia.

Patrick Jones1, Bhavan Prasad Rai2, Omar M Aboumarzouk3, Bhaskar K Somani4.   

Abstract

Prostate urethral lift and prostate arterial embolization represent two evolving techniques with contrasting mechanisms of action (mechanical decompression vs angiographic embolization). Both yield relief of lower urinary tract symptoms over a period of several weeks. They display similar safety profiles with self-limiting pelvic discomfort characterizing the commonest minor adverse event. Both procedures have the potential to be carried out under local anesthesia and in the outpatient setting with suitability for patients with cardiovascular comorbidities. Neither has been found to cause degradation of sexual function. Further randomized studies are needed to delineate the formal position of these techniques in the surgical management of benign prostate hyperplasia.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26494293     DOI: 10.1016/j.urology.2015.10.005

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

Review 1.  Aquablation: a novel and minimally invasive surgery for benign prostate enlargement.

Authors:  Samih Taktak; Patrick Jones; Ahsanul Haq; Bhavan Prasad Rai; Bhaskar K Somani
Journal:  Ther Adv Urol       Date:  2018-02-26

2.  Urolift: a new chapter in benign prostate hyperplasia (BPH) therapy.

Authors:  Patrick Jones; Bhavan Prasad Rai; Omar M Aboumarzouk; Bhaskar K Somani
Journal:  Ann Transl Med       Date:  2016-03

Review 3.  UroLift: a new minimally-invasive treatment for benign prostatic hyperplasia.

Authors:  Patrick Jones; Bhavan P Rai; Omar Aboumarzouk; Bhaskar K Somani
Journal:  Ther Adv Urol       Date:  2016-10-10

4.  Safety and efficacy of prostatic artery embolization for large benign prostatic hyperplasia in elderly patients.

Authors:  Chen Xu; Gang Zhang; Jin-Jin Wang; Chun-Xian Zhou; Min-Jun Jiang
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.